Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.54 |
| ▸ | HPGD | P15428 | 7/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | EGFR | P00533 | 4/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.54 |
| ▸ | RECQL | P46063 | 3/20 | 0.54 |
| ▸ | BLM | P54132 | 3/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | GMNN | O75496 | 2/20 | 0.54 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4662121 | 0.87 | ALDH1A1 (0.54) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL7466157 | 0.82 | TRPV1 (0.55) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL7467689 | 0.78 | ALDH1A1 (0.54) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL1934841 | 0.77 | ALDH1A1 (0.55) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL1315136 | 0.76 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL1315137 | 0.76 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL1315133 | 0.76 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL1315140 | 0.76 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL1935665 | 0.76 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL7456816 | 0.74 | BCL2A1 (0.48) | ALDH1A1HPGDKDM4EMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2506852-A2 | INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION | Board Of Regents, The University Of Texas System (US) | 2012-10-10 | — | — | EP | disclosed |
| WO-2011069141-A2 | INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-06-09 | — | — | WO | disclosed |
| EP-2007714-A2 | ORALLY BIOAVAILABLE CAFFEIC ACID RELATED ANTICANCER DRUGS | The Board of Regents of The University of Texas System (US) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007115269-A2 | ORALLY BIOAVAILABLE CAFFEIC ACID RELATED ANTICANCER DRUGS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-10-11 | — | — | WO | disclosed |